YAP1 and central nervous system cancer: Wherein, Miao et al. [13] indicated that DLGAP1‐AS2 was highly expressed in gliomas and promoted the malignant phenotype of glioma cells by targeting YAP1. Nevertheless, the expression and function of DLGAP1‐AS2 in CCA have not been studied.